Transcript No Slide Title

Excellence Begins Here
Board of Directors
Mark Crowther, MD, President
Jack Ansell, MD
Allison Burnett, PharmD
David Garcia, MD
Scott Kaatz, DO
Renato Lopes, MD
Edith Nutescu, PharmD
Lynn Oertel, RN
Mike Streiff, MD
Terri Schnurr, RN
Diane Wirth, ANP
Daniel Witt, PharmD
Ann Wittkowsky, PharmD
Anticoagulation Forum
• Founded almost 25 years ago by Jack Ansell
• Largest organization for anticoagulation service
providers
• Provide unbiased education to healthcare
professionals to improve patient care
• Promote clinical application of evidence-based
practices
• Our experts provide clarity and an authoritative
voice on the changing landscape of
anticoagulation therapy
Who Are Our Members?
• Multidisciplinary membership –
physicians, pharmacists, nurses
• Current membership: over 6,000
• Number of clinics: 2,000
• Number of patients reached: 750,000
Key Initiatives
• Biennial National Conference
– April 23-25, 2015 in Washington, DC
– Over 900 attendees
– International expert faculty, posters, exhibits
• Anticoagulation Centers of Excellence
– Roadmap for best practices
– Rich library of current resources
• VTE Guidance Project
• Monthly Webinars
• Grand Rounds - AFib & VTE series at community-based hospitals
• Boot Camps - Comprehensive basic training in anticoagulation
Anticoagulation Centers of Excellence
• Launched in December 2012, and our flagship program, ACE
raises awareness & encourages clinical use of best practices and
evidence-based guidelines, improving care for all patients on all
antithrombotic medications.
• Website: excellence.acforum.org
How does ACE accomplish this goal?
• Interactive assessment tool
• Comprehensive Resource Center
• Highlights clinics through “Examples of Excellence”
Grand Rounds
• Stroke Prevention in AFib
– Round 1 – 16 live programs (975 total
attendees) and 1 enduring activity complete
– Round 2 – 10 live programs, began Feb 2014
• Venous Thromboembolism
– 20 live programs, began March 2014
– 1 enduring activity, online through October
2015
VTE Guidance
• Publishing comprehensive consensus and
evidence-based guidance for the treatment
of VTE
• Being published mid-2015
• Phase 2 will create slide decks and clinical
tools
• Support
• Two-day conference for those new to the field of
anticoagulation or want refresher course to bring them
up to date on the changing practice of anticoagulation
•
•
•
•
Miami, FL January, 2014
Seattle, WA October, 2014
Southwest location July 2015
East coast location October 2015
• Expert faculty, case-based learning, small personalized
learning model
• Limited enrollment; all programs have sold out
November 2014 Webinar - National Assessment of Warfarin
Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation;
November 20, 2014 1:00 pm EST
2014:
• Patient Webinar –DVT and PE Discussion in Honor of World Thrombosis Day
• Antibiotic Interaction with Warfarin in the Ambulatory Setting
• Dabigatran Plasma Concentrations, Ischemic Stroke & Major Bleeding in AFib
• Review of RE-COVER I and II: FDA Approves use of Dabigatran for treatment of acute VTE
• SOX Trial
• COAG
• BRUISE CONTROL
• RE-ALIGN
• Limited English Proficient Patients & Time in Therapeutic Range in a Warfarin Anticoag Clinic
• Centers of Excellence
2013:
•
•
•
•
•
•
•
•
ARISTOTLE – Apixaban v. warfarin for AFib
EINSTEIN – Rivaroxaban for VTE
PROTECT – Dalteparin v, unfractionated heparin in critically ill patients
Aspirin v. low molecular weight heparin after hip arthroplasty
FDA post marketing report on dabigatran
Inpatient consensus statement
CLOTS3 – pneumatic compression post stroke
Mgmt. and Outcomes – Major Bleeding with Dabigatran
National Action Plan for
Adverse Drug Event Prevention
•
•
US Dept. of Health & Human Services report focusing on
Anticoagulant, Diabetes Agents, Opioids
AC Forum highlighted as model for partnerships
•
Page 63 & 70 “Identify and promote adoption of standards that constitute
high-quality anticoagulation management e.g. Anticoagulation Centers of
Excellence”
•
Page 64 “Some organizations, such as the Anticoagulation Forum… are
leading strategies that foster dissemination of best practices and
prevention strategies across health care systems and facilities.”
•
Page 68 “Public-private partnerships with organizations such as the
Anticoagulation Forum, which also is facilitating widely and easily
accessible formats for provider education aimed at improving the quality of
anticoagulation care, could also be considered.”
Our Future
• Continuing our mission to educate
healthcare providers to improve outcomes
• Embracing the changing landscape of
anticoagulation
• Striving for outreach and collaboration in
support of improved patient care